Pharmaceutical Quality - Chemistry, Manufacturing and Controls (PQ-CMC) Submissions to FDA, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/FHIR-us-pq-cmc-fda/ and changes regularly. See the Directory of published versions
Generated Narrative: MedicinalProductDefinition
ResourceMedicinalProductDefinition "ddd3abad-347c-4d2f-95f3-dd804e250502"
Profile: Drug Product Impurities
identifier: TabletCoatedBeadsCoatedAll
description: A drug product composed of one type of bead with two coatings inside a coated tablet
combinedPharmaceuticalDoseForm: TABLET, MULTILAYER (PQ-CMC-FDA Temporary Codes#C42964)
Reference |
urn:uuid:58ae52aa-c81e-415a-8791-e67a3195290d |
urn:uuid:ffa30c0b-8031-436a-87f1-635b3bbe5989 |
name
productName: LEVOTHYROXINE SODIUM ANHYDROUS 125mg
type: Non-Proprietary (Product Name Types Code Types#NON)
part
part: LEVOTHYROXINE SODIUM ANHYDROUS
type: scientific name (EntityNamePartQualifierR2#SCI)
part
part: 125mg
type: LEVOTHYROXINE SODIUM ANHYDROUS (EntityNamePartQualifierR2#STR)